Alvogen subsidiary Lotus Pharmaceuticals has launched vinorelbine 20, 30 and 80mg soft capsules in Europe, it was announced today.
The product is the generic v 1 August 2019
The first UK product launches are underway for German central nervous system (CNS) specialist Neuraxpharm, guided by new UK general manager Craig Bowen. 31 July 2019
Israeli drugmaker Teva Pharmaceutical Industries has launched a generic version of the overactive bladder (OAB) drug VESIcare (solifenacin succinate) in the USA 23 April 2019
Zydus Cadila has received tentative approval from the US regulator to market Myrbetriq (mirabegron), an extended-release formulation selective beta 3-adrenocept 3 April 2019
The US Food and Drug Administration has updated the summary table forms for abbreviated new drug application submissions containing clinical endpoint studies. 12 February 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.